IL126185A0 - Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs - Google Patents
Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgsInfo
- Publication number
- IL126185A0 IL126185A0 IL12618597A IL12618597A IL126185A0 IL 126185 A0 IL126185 A0 IL 126185A0 IL 12618597 A IL12618597 A IL 12618597A IL 12618597 A IL12618597 A IL 12618597A IL 126185 A0 IL126185 A0 IL 126185A0
- Authority
- IL
- Israel
- Prior art keywords
- vitamin
- tpgs
- compositions
- compound
- water soluble
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1389396P | 1996-03-22 | 1996-03-22 | |
GBGB9606372.2A GB9606372D0 (en) | 1996-03-26 | 1996-03-26 | Pharmaceutical formulations |
PCT/EP1997/001438 WO1997035587A1 (en) | 1996-03-22 | 1997-03-21 | Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
Publications (2)
Publication Number | Publication Date |
---|---|
IL126185A0 true IL126185A0 (en) | 1999-05-09 |
IL126185A IL126185A (en) | 2003-05-29 |
Family
ID=26308992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12618597A IL126185A (en) | 1996-03-22 | 1997-03-21 | Compositions comprising an hiv protease inhibitor, a water soluble vitamin e compound and a hydrophilic non-aqueous solvent |
Country Status (12)
Country | Link |
---|---|
JP (1) | JP3117726B2 (en) |
AR (1) | AR006345A1 (en) |
BG (1) | BG64457B1 (en) |
CO (1) | CO4790151A1 (en) |
HU (1) | HU228026B1 (en) |
ID (1) | ID16781A (en) |
IL (1) | IL126185A (en) |
MY (1) | MY126358A (en) |
OA (1) | OA10880A (en) |
PL (1) | PL187919B1 (en) |
TW (1) | TW455491B (en) |
WO (1) | WO1997035587A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2264718C (en) * | 1996-09-01 | 2006-05-30 | Pharmos Corporation | Solid coprecipitates for enhanced bioavailability of lipophilic substances |
AU8145198A (en) * | 1997-06-16 | 1999-01-04 | Vertex Pharmaceuticals Incorporated | Methods of increasing the bioavailability of stable crystal polymorphs of a compound |
US5891845A (en) * | 1997-11-21 | 1999-04-06 | Fuisz Technologies Ltd. | Drug delivery systems utilizing liquid crystal structures |
ES2140329B1 (en) * | 1997-12-04 | 2000-10-16 | Univ Granada | USE OF MASLINIC ACID AS A PROTEASE INHIBITOR FOR THE TREATMENT OF DISEASE CAUSED BY THE VIRUSES OF ACQUIRED IMMUNODEFICIENCY. |
GB9812189D0 (en) * | 1998-06-05 | 1998-08-05 | Glaxo Group Ltd | Methods and compositions for increasing penetration of HIV protease inhibitors |
WO2002051414A1 (en) * | 2000-12-22 | 2002-07-04 | Takeda Chemical Industries, Ltd. | Medicinal compositions for oral use |
WO2004050068A1 (en) | 2002-11-29 | 2004-06-17 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
US7423004B2 (en) | 2003-01-31 | 2008-09-09 | Smithkline Beecham Corporation | Solid dispersion compositions |
EP1799194B1 (en) * | 2004-09-24 | 2011-11-16 | Boehringer Ingelheim Pharmaceuticals Inc. | A new class of surfactant-like materials comprising vitamin e tpgs and a water soluble polymer |
CN101031284A (en) * | 2004-09-30 | 2007-09-05 | 伊斯曼化学公司 | Pharmaceutical formulations containing vitamin e tpgs molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations |
EP1880715A1 (en) * | 2006-07-19 | 2008-01-23 | Abbott GmbH & Co. KG | Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
SA109300195B1 (en) | 2008-03-28 | 2013-04-20 | Astrazeneca Ab | A Novel Anti-Cancer Pharmaceutical Composition |
ITRM20120331A1 (en) | 2012-07-12 | 2014-01-13 | Guidotti & C Spa Labor | LIQUID ORAL PEDIATRIC COMPOSITIONS CONTAINING NEPADUTANT. |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1677092A (en) * | 1991-03-20 | 1992-10-21 | Vertex Pharmaceuticals Incorporated | Tetrahydroxyalkane derivatives as inhibitors of hiv aspartyl protease |
IL103613A (en) * | 1991-11-08 | 1999-05-09 | Merck & Co Inc | Hiv protease inhibitors process and intermediats for their preparation and pharmaceutical compositions containing them |
IS2334B (en) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl protease inhibitor of a new class of sulfonamides |
AU5748194A (en) * | 1992-12-11 | 1994-07-04 | Vertex Pharmaceuticals Incorporated | Mannitol derivatives and their use as inhibitors of aspartyl protease |
US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
JP2637847B2 (en) * | 1992-12-29 | 1997-08-06 | アボツト・ラボラトリーズ | Compounds that inhibit retroviral protease |
DE69418035T2 (en) * | 1993-01-15 | 1999-08-12 | Agouron Pharma | HIV PROTEAS INHIBITORS |
WO1995012583A1 (en) * | 1993-11-05 | 1995-05-11 | Merck & Co., Inc. | New quinazolines as inhibitors of hiv reverse transcriptase |
IL111584A0 (en) * | 1993-11-18 | 1995-01-24 | Merck & Co Inc | Prodrugs of an inhibitor of hiv protease and pharmaceutical compositions containing them |
PL314984A1 (en) * | 1993-12-15 | 1996-09-30 | Merck & Co Inc | Hiv protease inhibitors |
DE69512220T2 (en) * | 1994-03-07 | 2000-03-16 | Vertex Pharma | SULPHONAMIDE DERIVATIVES AS ASPARTYL PROTEASE INHIBITORS |
GB9409778D0 (en) * | 1994-05-16 | 1994-07-06 | Dumex Ltd As | Compositions |
US5527829A (en) * | 1994-05-23 | 1996-06-18 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
WO1996036316A1 (en) * | 1995-05-19 | 1996-11-21 | Abbott Laboratories | Self-emulsifying formulations of lipophilic drugs |
-
1997
- 1997-03-20 MY MYPI97001186A patent/MY126358A/en unknown
- 1997-03-21 WO PCT/EP1997/001438 patent/WO1997035587A1/en active IP Right Grant
- 1997-03-21 AR ARP970101146A patent/AR006345A1/en active IP Right Grant
- 1997-03-21 JP JP09534017A patent/JP3117726B2/en not_active Expired - Lifetime
- 1997-03-21 HU HU9901887A patent/HU228026B1/en unknown
- 1997-03-21 CO CO97015457A patent/CO4790151A1/en unknown
- 1997-03-21 TW TW086103607A patent/TW455491B/en not_active IP Right Cessation
- 1997-03-21 ID IDP970927A patent/ID16781A/en unknown
- 1997-03-21 IL IL12618597A patent/IL126185A/en not_active IP Right Cessation
- 1997-03-21 PL PL32891697A patent/PL187919B1/en unknown
-
1998
- 1998-09-18 OA OA9800171A patent/OA10880A/en unknown
- 1998-10-12 BG BG102838A patent/BG64457B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL328916A1 (en) | 1999-03-01 |
CO4790151A1 (en) | 1999-05-31 |
PL187919B1 (en) | 2004-11-30 |
HUP9901887A2 (en) | 1999-12-28 |
OA10880A (en) | 2001-10-11 |
HU228026B1 (en) | 2012-08-28 |
TW455491B (en) | 2001-09-21 |
ID16781A (en) | 1997-11-13 |
MY126358A (en) | 2006-09-29 |
HUP9901887A3 (en) | 2000-02-28 |
BG64457B1 (en) | 2005-03-31 |
WO1997035587A1 (en) | 1997-10-02 |
BG102838A (en) | 1999-09-30 |
AR006345A1 (en) | 1999-08-25 |
JP2000500504A (en) | 2000-01-18 |
IL126185A (en) | 2003-05-29 |
JP3117726B2 (en) | 2000-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL110752A0 (en) | Pharmaceutical composition for an hiv protease inhibitor | |
HU0900219D0 (en) | Hiv protease inhibitor | |
HUP0002932A3 (en) | Liquid composition comprising an hiv protease inhibitor and a c12-c18 fatty acid | |
HUP0104768A3 (en) | 4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same | |
HUP0103806A3 (en) | Serine protease inhibitor and pharmaceutical compositions containing them | |
IL109503A0 (en) | Hiv protease inhibitors and pharmaceutical compositions containing them | |
IL126185A0 (en) | Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs | |
PL322649A1 (en) | Surfactant compositions | |
HUP0201591A3 (en) | Pharmaceutical formulations comprising an hiv protease inhibitor | |
IL120311A0 (en) | Serine protease inhibitors and pharmaceutical compositions containing them | |
HUP0002951A3 (en) | Bis-aminomethylcarbonyl compounds as protease inhibitors and pharmaceutical compositions containing them | |
IL120310A0 (en) | Serine protease inhibitors and pharmaceutical compositions containing them | |
ZA949147B (en) | Pyrone derivatives as protease inhibitors and antiviral agents | |
EP0691345A3 (en) | HIV protease inhibitor combinations | |
NZ237733A (en) | Neutral metalloprotease inhibitors and pharmaceutical compositions | |
AU9061798A (en) | Protease variants and compositions | |
GB2284215B (en) | Concentrated surfactant compositions | |
CY2444B1 (en) | Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs. | |
ZA984514B (en) | Hiv protease inhibitor | |
HK1005778A1 (en) | Concentrated surfactant compositions | |
ZA943170B (en) | Aqueous based surfactant compositions | |
HK1022441A1 (en) | Liquid composition comprising an hiv protease inhibitor and a c12-c18 fatty acid | |
SI0729465T1 (en) | Pyrone derivatives as protease inhibitors and antiviral agents | |
IL138574A0 (en) | Amidino protease inhibitors and pharmaceutical compositions containing the same | |
GB9514653D0 (en) | Surfactant compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |